A series of new mono and disubstituted alkylated and methoxylated benzisoselanzol-3(2H)-ones and bis(2-carbamoylaryl)diselenides were prepared in yields ranging from 55% to 95% starting from anthranilic acid and were evaluated for antiviral and antimicrobial activity. The compounds exhibited antiviral activity against Human herpes virus 1 and Encephalomyocarditis virus as well as antimicrobial activity against Staphylococcus aureus, Bacillus subtilis, Escherichia coli and Candida albicans. 
Introduction
Over last few decades organoselenium compounds have been extensively studied in organic and medicinal chemistry. [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] Due to their unique properties, they attracted a wide interest as reagents in new synthetic routes, 3 promising catalysts for various oxidation reactions [1] [2] [3] [4] [5] [6] [7] [16] [17] [18] [19] and potential pharmaceuticals. [8] [9] [10] [11] [12] [13] [14] [15] 20, 21 Ebselen (2-phenylbenzisoselenazol-3(2H)-one) and its analogues have received particular attention as glutathione peroxidase mimics, 8, 11, 15 antioxidant and anti-inflammatory agents. [13] [14] [15] Furthermore, the continuing interest in this class of compounds has led to the development of various structures with antiviral [22] [23] [24] [25] [26] and antimicrobial [24] [25] [26] [27] properties. In this work we report a convenient synthetic route to a series of new alkylated and methoxylated benzisoselanazol-3(2H)-ones 4 and bis(2-carbamoylaryl)diselenides 6 which were tested for antiviral and antimicrobial activity in biological studies.
Results and Discussion
Searching for new antiviral and antimicrobial agents, we report here the synthesis of new alkylated and methoxylated analogues of ebselen -an organoselenium compound well known for its variety of biological and oxygen transfer properties. 2-Phenylbenzisoselanazol-3(2H)-ones alkylated and methoxylated on the benzene ring 4a-l were prepared through a tandem selenenylation-acylation of mono and disubstituted anilines with 2-(chloroseleno)benzoyl chloride (3) , in the presence of triethylamine as a base, whereas corresponding bis(2-carbamoylaryl) diselenides 6c,e,g-h,j-l were prepared via the reaction of the benzoyl chloride 5 with appropriate anilines in the presence of sodium carbonate (Scheme 1). Both benzoyl chlorides 3 and 5 were obtained in a three-step synthesis starting from anthranilic acid (1), which was diazotized and reacted with dilithium diselenide in aprotic medium (THF) to give after acidification 2,2'-diselenobisbenzoic acid 2 with 78 % yield. [28] [29] [30] Efficient cooling is important to reduce by-product formation such as salicylic acid. Dilithium diselenide was generated in situ from elemental lithium and selenium in the presence of 4,4'-di(tbutyl)biphenyl, as a catalyst. 31 Alternatively, disodium diselenide in protic medium (MeOH) can be used to introduce the diselenide moiety, however the yield was reported to be lower (18-67 %). 24, 32 The procedure for preparation of disodium diselenide is critical to obtain 2,2'-diselenobisbenzoic acid (2) with good yields. The type of reducing agent, such as hydrazine monohydrate, 24 and sodium tetrahydroborate 21 as well as reaction times up to 48 hours, are of particular importance. Some authors report yields even up to 95% however no synthetic details were provided. 20 The acid 2 was easily converted into 2-(chloroseleno)benzoyl chloride (3) (85%) with thionyl chloride, used in excess, in the presence of catalytic amounts of N,N'-dimethylformamide. 29 When thionyl chloride was used in excess (2.5 equivalents), chloride 5 (64%) was produced. 29 The reaction of benzoyl chlorides 3 and 5 with anilines substituted at ortho, meta or para positions of the phenyl ring by electron-donating methyl and/or strong electron-donating methoxy groups, (in some cases with a chlorine substituent) provides a straightforward way to obtain new mono and disubstituted 2-phenylbenzisoselanzol-3(2H)-ones 4 and bis(2-carbamoylaryl) diselenides 6, respectively. All products were prepared with good to excellent yields (Scheme 1). An ortho effect of methyl and methoxy groups, and a steric hindrance effect of the tert-butyl substituent in the case of formation of compound 4f, were not observed, only in the cases of selenazolones 4d, and 4j were minor effects of electron-withdrawing chlorine substituent observed. This confirms that the general approach presented here can be successfully used for preparation of new substitued analogues of ebselen. To our best knowledge compounds 4a-h, 4j, 6c, 6e, 6g, 6h, 6j, 6k are new structures and were not previously described in the literature. All compounds were fully characterized by spectroscopic methods (see Experimental Section). 
Antiviral and antimicrobial evaluation of organoselenium compounds
The alkylated and methoxylated analogues of ebselen 4 and 6 were evaluated for antiviral activity against Human herpes virus 1 (HHV-1, Herpesviridae, enveloped virus), Encephalomyocarditis virus (EMCV, Picornaviridae, non-enveloped virus) and Vesicular stomatitis virus (VSV, Rhabdoviridae, enveloped virus) as well as antimicrobial activity against Staphylococcus aureus, Bacillus subtilis, Escherichia coli and Candida albicans by serial dilution techniques. 26 Their activities were compared with those of ebselen. The compounds exhibited high antiviral activity against HHV-1 and EMCV but in almost all cases were inactive towards VSV (Table 1) . A similar tendency was observed in our previous studies. [24] [25] [26] Generally, benzisoselenazol-3(2H)-ones 4 were more active than corresponding diselenides 6. The results of screening of benzisoselenazol-3(2H)-ones 4 toward HHV-1 are particularly interesting. These compounds were more active than ebselen, with minimal inhibitory concentration (MIC) values in a range of 2 -6 μg/mL. The most promising as antiviral agents were compounds 4b-d and 6c with higher chemotherapeutic indices (I), indicating that the concentration active against virus was lower than that showing a cytotoxic effect. n.a 340 n.a n.a. n.a 6k 305 n.a n.a n.a. n.a 6l n.a n.a n.a n.a. n.a Ebselen 17 17 32 n.a. 128
a MIC -Minimal Inhibitory Concentration (µg/mL). n.a. -non-active, MIC > 512 µg/mL.
Benzisoselenazol-3(2H)-ones 4 were found to be active against S. aureus, B. subtilis, E. coli and C. albicans ( Table 2) . None of compounds exhibited antibacterial activity against P. aeruginosa which is in agreement with previous observations. 26 Usually this gram-negative bacterial strain is not sensitive to benzisoselenazol-3(2H)-ones and only a few structures were found to exhibit very low antibacterial activity towards it. 24, 26 Contrary to their cyclic analogues, diselenides appeared to be practically inactive against all tested microorganisms. Only 6e and 6k showed low activity against B. subtilis and S. aureus, respectively.
Conclusions
A series of new alkylated and methoxylated 2-phenylbenzisoselanzol-3(2H)-ones 4 and bis(2-carbamoylaryl)diselenides 6 were prepared in good to excellent yields starting from anthranilic acid. This general approach proved to be convenient for the preparation of various mono-and disubstituted analogues of ebselen. The studies of antiviral and antimicrobial activity revealed new potential antiviral agents against HHV-1 and EMCV, and antimicrobial agents against Staphylococcus aureus, Bacillus subtilis, Escherichia coli and Candida albicans.
Experimental Section
General. Melting points were determined on an Electrothermal IA 91100 digital melting-point apparatus using the standard open capillary method. Selenium powder (100 mesh) with purity ≥99.5% used for Li2Se2 or Na2Se2 preparation was purchased from Aldrich. Freshly distilled acetonitrile (MeCN) was redistilled twice over P2O5 to obtain the anhydrous MeCN for preparation of the ebselen derivatives 4. Methylene chloride (CH2Cl2) was distilled over P2O5 before preparation of diselenides 6. Distilled triethylamine was stored over NaOH pellets. Other reagents and starting materials were directly used as obtained commercially. Purity of the products was confirmed by comparison of their melting point with data given in the literature and by spectroscopic methods.
2,2'-Diselenobisbenzoic acid (2) was prepared from anthranilic acid, using dilithium diselenide, 30 following the method previously reported 28 with some modifications. The crude product was recrystallized from 1,4-dioxane by slow evaporation under ca. 200 mmHg from a water bath at ca 75 °C to give 2,2'-diselenobisbenzoic acid (2) with 85% yield as pale crystals, mp 299-300 °C (lit. 30 
300-303 °C).
2-(Chloroseleno)benzoyl chloride (3) was prepared from 2,2'-diselenobisbenzoic acid (2) using excess of thionyl chloride, following the method previously reported. 29 Crude oily product was recrystallized from nhexane and dried under vacuum (200 mmHg) to give 2-(chloroseleno)benzoyl chloride (3) as yellow needles, mp 65-67 °C (lit. 29 
65-66 °C).
Bis[(2-chlorocarbonyl)phenyl)] diselenide (5) was prepared from 2,2'-diselenobisbenzoic acid (2), using thionyl chloride in excess of 2.5 equivalents, following the method previously reported. 29 The crude oily product was washed with n-hexane, recrystallized from CH2Cl2 and dried under vacuum to give bis[(2-chlorocarbonyl)phenyl)] diselenide (5) as pale greenish yellow prisms, mp 180-181 °C (lit. 29 
174-175 °C).

General synthetic procedure for benzisoselenazol-3(2H)-ones 4.
To a stirred solution of substituted aniline (5.0 mmol) and dry triethylamine (1.8 ml, 1.02 g, 12.5 mmol) in anhydrous MeCN (50 mL) a solution of (2-chloroseleno)benzoyl chloride 3 (1.27 g, 5.0 mmol) in anhydrous MeCN (25 mL) was slowly added dropwise for 1 h. The reaction was continued for 1-48 h. The progress of reaction was monitored by TLC. After the reaction finished, the solvent was evaporated and water was added dropwise (100 mL) resulting in the product precipitation. Crude product was washed with water and 3.5% HCl if TLC indicated unreacted amine, and left to dry on the air. Methoxy-2-methylphenyl)benzisoselenazol-3(2H)-one (4a) Chloro-5-methylphenyl)benzisoselenazol-3(2H)-one (4g) 2-(2-Chloro-4-methylphenyl)benzisoselenazol-3(2H)-one (4h) General synthetic procedure for bis(2-carbamoylaryl) diselenides 6. To a stirred solution of substituted aniline (1.0 mmol) in dry CH2Cl2 (5 mL) Na2CO3 (2.5 mmol, 0.265 g) was added. Next, the solution of chloride 5 in dry CH2Cl2 was added dropwise for 30 min. The desired product, diselenide precipitated immediately. The reaction progress was controlled by TLC. The stirring was continued for 1-48 h. The product was filtered off and washed with dry CH2Cl2 (2 x 5 mL), water (1 x 5 mL) and 3.5% HCl (3 x 5 mL). 35 (s, 6H, CH3 ), 7.38-7.50 (m, 6H, ArH-5, PhH-Evaluation of antiviral activity and cytotoxicity. The compounds 4 and 6 at various concentrations were incubated with following viruses: HHV-1 (human herpes virus type 1), EMCV (encephalomyocarditis virus) and VSV (vesicular stomatitis virus) for 1 hr at RT. The HHV-1 was used at the dose of 10 6 TCID50/mL, whereas EMCV and VSV at the dose of 10 8 TCID50/mL. The TCID50 (tissue culture infectious dose) determines the cytopathic effect caused by the virus in about 50% of infected cells. The virus titer was measured in human cell line A549 (human lung adenocarcinoma cell line, ATCC 185) which was observed for cytopathic effect after 48 h. The minimal concentration that caused 1000-fold decrease of virus titer was taken as minimal inhibitory concentration, MIC (μg/mL). In parallel, the cytotoxicity of the compounds was determined in A549 cell line (cell line used in antiviral activity test) by incubation at various concentrations for 48 h at 37 o C in the atmosphere of 5% CO2 in air. The minimal concentration which was toxic to approximately 50% of the cells was taken as TCCD50. Both, cytotoxicity and virus titers were determined using MTT assay. To ensure that colourful compounds did not interfere with MTT reagents, extent of cell damage was evaluated by microscopic examination prior to MTT assay.
2-(4-
2-(4-Chloro-3-methylphenyl)benzisoselenazol-3(2H)-one (4c)
.
2-(2-
Evaluation of antimicrobial activity. Antimicrobial activity of compounds 4 and 6 was determined by serial dilution method using gram-positive bacterial strains: Staphylococcus aureus PCM 1944, Bacillus subtilis PCM 1949, gram-negative bacterial strains: Escherichia coli PCM 2057, Pseudomonas aeruginosa PCM 2058 and yeast Candida albicans ATCC 90028 obtained from the Polish Collection of Microorganisms, following procedure previously described. 26 The antimicrobial activity was characterized by MIC value which is minimal concentration of the compound in μg/ml that totally inhibits growth of the microorganisms.
